Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells
Cellular Oncology · 2025
DOI: 10.1007/s13402-024-00982-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Stanislav Drápela und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, Brno, 612 00, Czech Republic. Hauptthemen laut MEDLINE: Docetaxel, Drug Resistance, Neoplasm, Prostatic Neoplasms. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Biophysics of the Czech Academy of Sciences.
Abstract (Originalsprache)
Purpose
Docetaxel resistance is a significant obstacle in the treatment of prostate cancer (PCa), resulting in unfavorable patient prognoses. Intratumoral heterogeneity, often associated with epithelial-to-mesenchymal transition (EMT), has previously emerged as a phenomenon that facilitates adaptation to various stimuli, thus promoting cancer cell diversity and eventually resistance to chemotherapy, including docetaxel. Hence, understanding intratumoral heterogeneity is essential for better patient prognosis and the development of personalized treatment strategies.
Methods
To address this, we employed a high-throughput single-cell flow cytometry approach to identify a specific surface fingerprint associated with docetaxel-resistance in PCa cells and complemented it with proteomic analysis of extracellular vesicles. We further validated selected antigens using docetaxel-resistant patient-derived xenografts in vivo and probed primary PCa specimens to interrogate of their surface fingerprint.
Results
Our approaches revealed a 6-molecule surface fingerprint linked to docetaxel resistance in primary PCa specimens. We observed consistent overexpression of CD95 (FAS/APO-1), and SSEA-4 surface antigens in both in vitro and in vivo docetaxel-resistant models, which was also observed in a cell subpopulation of primary PCa tumors exhibiting EMT features. Furthermore, CD95, along with the essential enzymes involved in SSEA-4 synthesis, ST3GAL1, and ST3GAL2, displayed a significant increase in patients with PCa undergoing docetaxel-based therapy, correlating with poor survival outcomes.
Conclusion
In summary, we demonstrate that the identified 6-molecule surface fingerprint associated with docetaxel resistance pre-exists in a subpopulation of primary PCa tumors before docetaxel treatment. Thus, this fingerprint warrants further validation as a promising predictive tool for docetaxel resistance in PCa patients prior to therapy initiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, Brno, 612 00, Czech Republic.
- International Clinical Research Center, St. Anne's University Hospital in Brno, Brno, 602 00, Czech Republic.
- Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, 625 00, Czech Republic.
- Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, FL, 33612, Tampa, USA.
- Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, 779 00, Czech Republic.
- Department of Urology, University Hospital Olomouc, Olomouc, 779 00, Czech Republic.
Förderung
- Institute of Biophysics of the Czech Academy of Sciences
Zitieren
APA
Drápela, S., Kvokačková, B., Slabáková, E., Kotrbová, A., Gömöryová, K., Fedr, R., Kurfürstová, D., Eliáš, M., Študent, V., Lenčéšová, F., Ranjani, G. S., Pospíchalová, V., Bryja, V., van Weerden, W. M., Puhr, M., Culig, Z., Bouchal, J., & Souček, K. (2025). Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells. Cellular Oncology. https://doi.org/10.1007/s13402-024-00982-2
Vancouver
Drápela S, Kvokačková B, Slabáková E, Kotrbová A, Gömöryová K, Fedr R, et al. Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells. Cellular Oncology. 2025. doi:10.1007/s13402-024-00982-2
BibTeX
@article{Drpela2025,
author = {Drápela, Stanislav and Kvokačková, Barbora and Slabáková, Eva and Kotrbová, Anna and Gömöryová, Kristína and Fedr, Radek and Kurfürstová, Daniela and Eliáš, Martin and Študent, Vladimír and Lenčéšová, Frederika and Ranjani, Ganji Sri and Pospíchalová, Vendula and Bryja, Vítězslav and van Weerden, Wytske M and Puhr, Martin and Culig, Zoran and Bouchal, Jan and Souček, Karel},
title = {Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells},
journal = {Cellular Oncology},
year = {2025},
doi = {10.1007/s13402-024-00982-2}
}
EUVIMED